Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-04

FDA Approved: XURIDEN — Original Application (BTG International Inc)

View source ↗

Summary

The FDA approved XURIDEN (uridine triacetate) as an original New Drug Application from BTG International Inc for the treatment of hereditary orotic aciduria. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XURIDEN (uridine triacetate)

Snippet

ORIG AP for XURIDEN (URIDINE TRIACETATE)